Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
This study has been completed.
Study NCT00652054   Information provided by Taiho Pharma USA, Inc.

First Received on March 31, 2008.   Last Updated on March 17, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Neoplasms
Neoplasms, Second Primary
Pancreatic Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms by Site
Pancreatic Diseases
Interventions listed in this trial
S-1
Sponsors listed in this trial
Taiho Pharma USA, Inc.
Quintiles


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services